JnJ Tremfya gets USFDA nod for pediatric plaque psoriasis, active psoriatic arthritis We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Mankind Pharma wins CDSCO nod to start Phase 1 trials of Autoimmune drug candidate We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Mankind Pharma on Monday said it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to initiate a Phase 1 clinical trial for a molecule under development for the treatment of multiple autoimmune disorders. The molecule is being developed for the treatment of multiple autoimmune disorders, including rheumatoid arthritis, ulcerative colitis, plaque psoriasis,…
Roflumilast Cream 0.3% Safe and Effective for Plaque Psoriasis in Children Aged 2–11 Years: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Revise Phase III Trial Protocol for Roflumilast Cream: CDSCO Panel Tells Sun Pharma We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Dr Reddy’s Gets CDSCO Panel Approval To Begin Phase III Trial of Tapinarof Cream We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link